Please login to the form below

Not currently logged in
Email:
Password:

David Theil joins Noxilizer as chief financial officer

He also takes up the role of senior vice president

US-based biotech Noxilizer has appointed David Theil as its new chief financial officer and senior vice president.

Theil has over 25 years of experience in financial, administrative and operational management, specialising in start-up and middle market life sciences companies.

Before joining the biotechnology firm, Theil held various senior management positions at IGEN International, Speciality Pharmaceuticals and Supernus Pharmaceuticals.

He has also served as manager of emerging business markets group for Deloitte & Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

Lawrence Bruder, Noxilizer's president and chief executive officer, said: “David brings experience that is critical to Noxilizer at this stage of the company.

“He has worked in growing companies and understands the opportunities and challenges.”

28th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics